Erythema nodosum: Etiological factors and relapses in a retrospective cohort study

European Journal of Dermatology

Volumn 20, Issue 6, 2010, Pages 773-777

  Papagrigoraki, Anastasia ^a   Gisondi, Paolo ^a   Rosina, Paolo ^a   Cannone, Manuela ^a   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Drugs; Erythema nodosum; Infections; Recurrence

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; IBUPROFEN; MACROLIDE; MESTEROLONE; MONTELUKAST; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PROGESTERONE; SEX HORMONE; SULFANILAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHILD; DISEASE ASSOCIATION; ERYTHEMA NODOSUM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRESCHOOL CHILD; RELAPSE; SCHOOL CHILD; SYSTEMIC DISEASE;

ADULT; ERYTHEMA NODOSUM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78649875021     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1116     Document Type: Article

References (24)

1. Requena L, Sánchez Yus E. Erythema nodosum. Semin Cutan Med Surg 2007; 26: 114-25.
2. Jones JV, Cumming RH, Asplin CM, Laszlo G, White RJ. Letter: Circulating immune complexes in erythema nodosum and early sarcoidosis. Lancet 1976; 1: 153.
3. Kunz M, Beutel S, Bröcker E. Leucocyte activation in erythema nodosum. Clin Exp Dermatol 1999; 24: 396-401.
4. Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician 2007; 75: 695-700. (Pubitemid 46397886)
5. Erez A, Horowitz J, Sukenik S. Erythema nodosum in the negev area-a survey of 50 patients. Isr J Med Sci 1987; 23: 1228-31. (Pubitemid 18068048)
6. Mert A, Kumbasar H, Ozaras R, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol 2007; 25: 563-70. (Pubitemid 47455465)
7. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 1998; 37: 667-72. (Pubitemid 28428316)
8. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodonum: an experience of ten years. Scand J Infect dis 2004; 36: 424-7.
9. García-Porrúa C, González-Gay MA, Vázquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43: 584-92. (Pubitemid 30394950)
10. Psychos DN, Voulgari PV, Skopouli FN, Drosos AA, Moutsopoulos HM. Erythema nodosum: the underlying conditions. Clin Rheumatol 2000; 19: 212-6.
11. Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf 2007; 30: 1011-30. (Pubitemid 350036602)
12. Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-22. (Pubitemid 37541988)
13. Benahmed S, Picot MC, Hillaire-Buys D, Blayac JP, Dujols P, Demoly P. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol 2005; 61: 537-41.
14. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-63.
15. Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematous. Arch Dermatol Res 2009; 301: 99-105.
16. Labunski S, Posern G, Ludwig S, Kundt G, Bröker EB, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81: 18-21.
17. Mana J, Marcoval J. Erythema nodosum. Clin Dermatol 2007; 25: 288-94.
18. Amoli MM, Thomson W, Hajeer AH, et al. HLA-DRB1 associations in biopsy proven erythema nodosum. J Rheumatol 2001; 28: 2660-2. (Pubitemid 33135652)
19. Jhaveri K, Halperin P, Shin SJ, Vahdat L. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Res Treat 2007; 106: 315-8. (Pubitemid 350029693)
20. Soderstrom RM, Krull EA. Erythema nodosum. A review. Cutis 1978; 21: 806-10.
21. Vashisht P, Sahoo B, Khurana N, Reddy BS. Cutaneous tuberculosis in children and adolescents: a clinico-histological study. J Eur Acad Dermatol Venereol 2007; 21: 40-7.
22. Crystal RG. Sarcoidosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. New York: McGrow-Hill Ltd, 2001: 1969-74.
23. McDougal KE, Fallin MD, Moller DR, Song Z, Culter DJ, Steiner LJ, Cutting GR and ACCESS Research group. Variationi in the lynphotoxin-α/Tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol 2009; 129: 1921-26.
24. Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine 2008; 87: 281-93.